The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths in the world. Metabolic reprogramming is considered a new hallmark of cancer, but it remains unclearly described in HCC. The dysregulation of the PI3K/AKT/mTOR signaling pathway is common in HCC and is, therefore, a...
Main Authors: | Ling-Yu Tian, Daniel J. Smit, Manfred Jücker |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/3/2652 |
Similar Items
-
Metabolic Reprogramming of HCC: A New Microenvironment for Immune Responses
by: Beatrice Foglia, et al.
Published: (2023-04-01) -
Metabolic influences on T cell in psoriasis: a literature review
by: Rina Su, et al.
Published: (2023-11-01) -
Epithelial–Mesenchymal Transition (EMT) Induced by TGF-β in Hepatocellular Carcinoma Cells Reprograms Lipid Metabolism
by: Jitka Soukupova, et al.
Published: (2021-05-01) -
Extracellular Matrix Stiffness: New Areas Affecting Cell Metabolism
by: Heming Ge, et al.
Published: (2021-02-01) -
Dietary chokeberry and dried jujube fruit attenuates high-fat and high-fructose diet-induced dyslipidemia and insulin resistance via activation of the IRS-1/PI3K/Akt pathway in C57BL/6 J mice
by: Oeuk Jeong, et al.
Published: (2019-06-01)